13th St. Gallen international breast cancer conference 2013: Primary therapy of early breast cancer evidence, controversies, consensus - Opinion of a German team of experts (Zurich 2013)

Michael Untch; Bernd Gerber; Nadia Harbeck; Christian Jackisch; Norbert Marschner; Volker Möbus; Gunter Von Minckwitz; Sibylle Loibl; Matthias W. Beckmann; Jens Uwe Blohmer; Serban Dan Costa; Thomas Decker; Ingo Diel; Thomas Dimpfl; Wolfgang Eiermann; Tanja Fehm; Klaus Friese; Fritz Jänicke; Wolfgang Janni; Walter Jonat; Marion Kiechle; Uwe Köhler; Hans Joachim Lück; Nicolai Maass; Kurt Possinger; Achim Rody; Anton Scharl; Andreas Schneeweiss; Christoph Thomssen; Diethelm Wallwiener; Anja Welt

doi:10.1159/000351692

13th St. Gallen international breast cancer conference 2013: Primary therapy of early breast cancer evidence, controversies, consensus - Opinion of a German team of experts (Zurich 2013)

Michael Untch^*, Bernd Gerber, Nadia Harbeck, Christian Jackisch, Norbert Marschner, Volker Möbus, Gunter Von Minckwitz, Sibylle Loibl, Matthias W. Beckmann, Jens Uwe Blohmer, Serban Dan Costa, Thomas Decker, Ingo Diel, Thomas Dimpfl, Wolfgang Eiermann, Tanja Fehm, Klaus Friese, Fritz Jänicke, Wolfgang Janni, Walter JonatMarion Kiechle, Uwe Köhler, Hans Joachim Lück, Nicolai Maass, Kurt Possinger, Achim Rody, Anton Scharl, Andreas Schneeweiss, Christoph Thomssen, Diethelm Wallwiener, Anja Welt

^*Corresponding author for this work

Clinic of Gynecology and Obstetrics

115 Citations (Scopus)

Abstract

The International Consensus Conference on the treatment of primary breast cancer takes place every two years in St. Gallen, Switzerland. The panel in St. Gallen is composed of international experts from different countries. From a German perspective, it seems reasonable to interpret the voting results in the light of AGO-recommendations and S3-guidelines for everyday practice in Germany. Consequently, a team of eight breast cancer experts, of whom two are members of the international St. Gallen panel, commented on the voting results of the St. Gallen Consensus Conference (2013). The main topics at this year's St. Gallen conference were surgical issues of the breast and axilla, radio-therapeutic and systemic treatment options, and the clinical relevance of tumour biology. The clinical utility of multigene assays for supporting individual treatment decisions was also intensively discussed.

Original language	English
Journal	Breast Care
Volume	8
Issue number	3
Pages (from-to)	221-229
Number of pages	9
ISSN	1661-3791
DOIs	https://doi.org/10.1159/000351692
Publication status	Published - 01.06.2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1159/000351692

Cite this

Untch, M., Gerber, B., Harbeck, N., Jackisch, C., Marschner, N., Möbus, V., Von Minckwitz, G., Loibl, S., Beckmann, M. W., Blohmer, J. U., Costa, S. D., Decker, T., Diel, I., Dimpfl, T., Eiermann, W., Fehm, T., Friese, K., Jänicke, F., Janni, W., ... Welt, A. (2013). 13th St. Gallen international breast cancer conference 2013: Primary therapy of early breast cancer evidence, controversies, consensus - Opinion of a German team of experts (Zurich 2013). Breast Care, 8(3), 221-229. https://doi.org/10.1159/000351692

@article{36065ee5d3c04f449cf3f4c2b007bfc3,

title = "13th St. Gallen international breast cancer conference 2013: Primary therapy of early breast cancer evidence, controversies, consensus - Opinion of a German team of experts (Zurich 2013)",

abstract = "The International Consensus Conference on the treatment of primary breast cancer takes place every two years in St. Gallen, Switzerland. The panel in St. Gallen is composed of international experts from different countries. From a German perspective, it seems reasonable to interpret the voting results in the light of AGO-recommendations and S3-guidelines for everyday practice in Germany. Consequently, a team of eight breast cancer experts, of whom two are members of the international St. Gallen panel, commented on the voting results of the St. Gallen Consensus Conference (2013). The main topics at this year's St. Gallen conference were surgical issues of the breast and axilla, radio-therapeutic and systemic treatment options, and the clinical relevance of tumour biology. The clinical utility of multigene assays for supporting individual treatment decisions was also intensively discussed.",

author = "Michael Untch and Bernd Gerber and Nadia Harbeck and Christian Jackisch and Norbert Marschner and Volker M{\"o}bus and \{Von Minckwitz\}, Gunter and Sibylle Loibl and Beckmann, \{Matthias W.\} and Blohmer, \{Jens Uwe\} and Costa, \{Serban Dan\} and Thomas Decker and Ingo Diel and Thomas Dimpfl and Wolfgang Eiermann and Tanja Fehm and Klaus Friese and Fritz J{\"a}nicke and Wolfgang Janni and Walter Jonat and Marion Kiechle and Uwe K{\"o}hler and L{\"u}ck, \{Hans Joachim\} and Nicolai Maass and Kurt Possinger and Achim Rody and Anton Scharl and Andreas Schneeweiss and Christoph Thomssen and Diethelm Wallwiener and Anja Welt",

year = "2013",

month = jun,

day = "1",

doi = "10.1159/000351692",

language = "English",

volume = "8",

pages = "221--229",

journal = "Breast Care",

issn = "1661-3791",

publisher = "S. Karger AG",

number = "3",

}

Untch, M, Gerber, B, Harbeck, N, Jackisch, C, Marschner, N, Möbus, V, Von Minckwitz, G, Loibl, S, Beckmann, MW, Blohmer, JU, Costa, SD, Decker, T, Diel, I, Dimpfl, T, Eiermann, W, Fehm, T, Friese, K, Jänicke, F, Janni, W, Jonat, W, Kiechle, M, Köhler, U, Lück, HJ, Maass, N, Possinger, K, Rody, A, Scharl, A, Schneeweiss, A, Thomssen, C, Wallwiener, D & Welt, A 2013, '13th St. Gallen international breast cancer conference 2013: Primary therapy of early breast cancer evidence, controversies, consensus - Opinion of a German team of experts (Zurich 2013)', Breast Care, vol. 8, no. 3, pp. 221-229. https://doi.org/10.1159/000351692

13th St. Gallen international breast cancer conference 2013: Primary therapy of early breast cancer evidence, controversies, consensus - Opinion of a German team of experts (Zurich 2013). / Untch, Michael; Gerber, Bernd; Harbeck, Nadia et al.
In: Breast Care, Vol. 8, No. 3, 01.06.2013, p. 221-229.

Research output: Journal Articles › Journal articles › Research › peer-review

TY - JOUR

T1 - 13th St. Gallen international breast cancer conference 2013: Primary therapy of early breast cancer evidence, controversies, consensus - Opinion of a German team of experts (Zurich 2013)

AU - Untch, Michael

AU - Gerber, Bernd

AU - Harbeck, Nadia

AU - Jackisch, Christian

AU - Marschner, Norbert

AU - Möbus, Volker

AU - Von Minckwitz, Gunter

AU - Loibl, Sibylle

AU - Beckmann, Matthias W.

AU - Blohmer, Jens Uwe

AU - Costa, Serban Dan

AU - Decker, Thomas

AU - Diel, Ingo

AU - Dimpfl, Thomas

AU - Eiermann, Wolfgang

AU - Fehm, Tanja

AU - Friese, Klaus

AU - Jänicke, Fritz

AU - Janni, Wolfgang

AU - Jonat, Walter

AU - Kiechle, Marion

AU - Köhler, Uwe

AU - Lück, Hans Joachim

AU - Maass, Nicolai

AU - Possinger, Kurt

AU - Rody, Achim

AU - Scharl, Anton

AU - Schneeweiss, Andreas

AU - Thomssen, Christoph

AU - Wallwiener, Diethelm

AU - Welt, Anja

PY - 2013/6/1

Y1 - 2013/6/1

N2 - The International Consensus Conference on the treatment of primary breast cancer takes place every two years in St. Gallen, Switzerland. The panel in St. Gallen is composed of international experts from different countries. From a German perspective, it seems reasonable to interpret the voting results in the light of AGO-recommendations and S3-guidelines for everyday practice in Germany. Consequently, a team of eight breast cancer experts, of whom two are members of the international St. Gallen panel, commented on the voting results of the St. Gallen Consensus Conference (2013). The main topics at this year's St. Gallen conference were surgical issues of the breast and axilla, radio-therapeutic and systemic treatment options, and the clinical relevance of tumour biology. The clinical utility of multigene assays for supporting individual treatment decisions was also intensively discussed.

AB - The International Consensus Conference on the treatment of primary breast cancer takes place every two years in St. Gallen, Switzerland. The panel in St. Gallen is composed of international experts from different countries. From a German perspective, it seems reasonable to interpret the voting results in the light of AGO-recommendations and S3-guidelines for everyday practice in Germany. Consequently, a team of eight breast cancer experts, of whom two are members of the international St. Gallen panel, commented on the voting results of the St. Gallen Consensus Conference (2013). The main topics at this year's St. Gallen conference were surgical issues of the breast and axilla, radio-therapeutic and systemic treatment options, and the clinical relevance of tumour biology. The clinical utility of multigene assays for supporting individual treatment decisions was also intensively discussed.

UR - https://www.scopus.com/pages/publications/84880741094

U2 - 10.1159/000351692

DO - 10.1159/000351692

M3 - Journal articles

AN - SCOPUS:84880741094

SN - 1661-3791

VL - 8

SP - 221

EP - 229

JO - Breast Care

JF - Breast Care

IS - 3

ER -

13th St. Gallen international breast cancer conference 2013: Primary therapy of early breast cancer evidence, controversies, consensus - Opinion of a German team of experts (Zurich 2013)

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this